These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1503504)

  • 1. The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action.
    Hegemann L; Fruchtmann R; van Rooijen LA; Müller-Peddinghaus R; Mahrle G
    Arch Dermatol Res; 1992; 284(3):179-83. PubMed ID: 1503504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
    Müller K
    Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthralin: how does it act and are there more favourable derivatives?
    Mahrle G; Bonnekoh B; Wevers A; Hegemann L
    Acta Derm Venereol Suppl (Stockh); 1994; 186():83-4. PubMed ID: 8073848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
    Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
    Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
    Kavanagh GM; Burton JL; Donnell VO
    Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
    Tanzer H; Braun C; Seidel M; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that inhibition of phorbol ester-induced superoxide anion formation by cyclosporin A in phagocytes is not mediated by direct inhibition of protein kinase C.
    Wenzel-Seifert K; Schächtele C; Hummel R; Grünbaum L; Seifert R
    Biochem Pharmacol; 1994 Aug; 48(5):859-64. PubMed ID: 8093097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
    Kemény L; Ruzicka T; Braun-Falco O
    Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of protein kinase c inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat.
    Wang JP; Lin PL; Hsu MF; Chen CC
    J Pharm Pharmacol; 1998 Oct; 50(10):1167-72. PubMed ID: 9821665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
    Schallreuter KU; Pittelkow MR
    Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthralin, a non-TPA type tumor promoter, synergistically enhances phorbol ester-caused prostaglandin E2 release from primary cultured mouse epidermal cells.
    Aizu E; Yamamoto S; Kato R
    Jpn J Pharmacol; 1992 Sep; 60(1):9-17. PubMed ID: 1460809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthralin, a non-phorbol tumor promoter, fails to inhibit metabolic cooperation in mutant human fibroblasts, but inhibits phytohemagglutinin-induced lymphocyte blastogenesis in vitro.
    Si EC; Pfeifer RW; Yim GK
    Toxicology; 1988 Dec; 53(2-3):199-212. PubMed ID: 3212783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Wiegrebe W; Müller K
    Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
    Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes.
    Hegemann L; Fruchtmann R; Bonnekoh B; Schmidt BH; Traber J; Mahrle G; Müller-Peddinghaus R; van Rooijen LA
    Arch Dermatol Res; 1991; 283(7):456-60. PubMed ID: 1801655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human neutrophil protein kinase C activity by the antimalarial drug mefloquine.
    el Benna J; Hakim J; Labro MT
    Biochem Pharmacol; 1992 Feb; 43(3):527-32. PubMed ID: 1311582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes.
    Peus D; Beyerle A; Rittner HL; Pott M; Meves A; Weyand C; Pittelkow MR
    J Invest Dermatol; 2000 Apr; 114(4):688-92. PubMed ID: 10733674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.